Cronos Group Inc. (CRON)
| Previous close | 2.7100 |
| Open | 2.7500 |
| Bid | 2.6700 x 400 |
| Ask | 2.6900 x 100 |
| Day's range | 2.6300 - 2.8850 |
| 52-week range | 1.6400 - 2.9900 |
| Volume | |
| Avg. volume | 3,276,667 |
| Market cap | 1.03B |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Cronos Group Inc. to Hold Virtual 2024 Annual Meeting of Shareholders
TORONTO, April 26, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 Annual Meeting of Shareholders on Thursday, June 20, 2024, at 11:00 a.m. ET. Cronos will be conducting the meeting in a virtual-only format via live audio webcast. Registered shareholders and duly appointed proxyholders will have an equal opportunity to participate in the 2024 Annual Meeting online regardless of their geographic location, including a chance to a
- GlobeNewswire
Cronos Group Inc. to Hold 2024 First Quarter Earnings Conference Call on May 9, 2024
TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 first quarter earnings conference call on Thursday, May 9, 2024 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events
- GlobeNewswire
Cronos Launches Lord Jones® Chocolate Fusions
Lord Jones® Chocolate Fusions Lord Jones® Chocolate Fusions Lord Jones® Cookies & Cream Chocolate Fusions Lord Jones® Cookies & Cream Chocolate Fusions Lord Jones® Dazzleberry Pop Chocolate Fusions Lord Jones® Dazzleberry Pop Chocolate Fusions Lord Jones® Salted Caramel Crunch Chocolate Fusions Lord Jones® Salted Caramel Crunch Chocolate Fusions TORONTO, March 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid c
